SciVision Biotech Inc.

Our vision

Leading Technology for Hyaluronic Acid
Science Creates Better Visions

More

Our vision

Leading Technology for Hyaluronic Acid
Science Creates Better Visions

More

Our vision

Leading Technology for Hyaluronic Acid
Science Creates Better Visions

More

Our vision

Leading Technology for Hyaluronic Acid
Science Creates Better Visions

More

Our vision

Leading Technology for Hyaluronic Acid
Science Creates Better Visions

More

Our vision

Leading Technology for Hyaluronic Acid
Science Creates Better Visions

More

Our vision

Leading Technology for Hyaluronic Acid
Science Creates Better Visions

More

Our vision

Leading Technology for Hyaluronic Acid
Science Creates Better Visions

More

Our vision

Leading Technology for Hyaluronic Acid
Science Creates Better Visions

More

Our vision

Leading Technology for Hyaluronic Acid
Science Creates Better Visions

More

Product description

SciVision Biotech Inc.
 
size_1920x1200

About Us

Founded in 2001, it is a professional R&D and production company of hyaluronic acid high-end medical equipment.

Annual Chronicle
01
  • 2024

    • CFS for Polycaprolactone (PCL) Dermal Implant
    • Poly-L-lactic acid (PLLA) launched
    • Taiwan Patent for the Method of Manufacturing Auto-Crosslinked Hyaluronic Acid Gel and Products Thereof Granted
more
Operational items
02

SciVision Biotech has products in four high-end medical device fields, including HA dermal filler in the facial aesthetic field, absorbable adhesion barrier in the surgery field, synovial fluid supplement for the field of elderly care, and intravesical instillation in the field of urology. We provide comprehensive care for the beauty and health of the human race.
 

more
SciVision five major advantages
03
  • R&D Capability
  • Patented CHAP Technology
  • Knowledge and Experiences
  • Production Capability
  • International Partnership
more

Our vision

SciVision adheres to a concept and spirit of continuous innovation to create a better vision for the human race.

More
size_560x420

Inverstor Relations

SciVision Biotech Inc.

Govermance

more

Financial Reports

more

Shareholder Services

more

Corporate information

SciVision Biotech Inc.
    • 2026 MEDICAL TAIWAN
    • 2026 MEDICAL TAIWAN

      See You at Medical Taiwan 2026! SciVision Biotech is excited to participate in Medical Taiwan 2026 this June in Taipei! As one of Asia’s key healthcare and medical technology exhibitions, Medical Taiwan brings together professionals and innovators from across the industry. We’re looking forward to sharing our latest developments and connecting with partners from around the world. Booth No. D0724 June 25–27, 2026 TWTC Exhibition Hall 1, Taipei ,Taiwan Stop by our booth and explore new possibilities in healthcare innovation with us We can’t wait to meet you in person!

      more
    • WHX MIAMI 2026
    • WHX MIAMI 2026

      WHX Miami is just around the corner! We are excited to announce our participation to one of the leading medical device exhibition held at Miami Beach Convention Center in the United States on June 17-19. We are looking forward to showcase innovations we are currently working on and find new potential opportunities in the fast-paced Latin American market. Our booth is #S51. Feel free to stop by our booth and to discuss the latest hyaluronic acid technologies with us! Booth: S51 June 17–19, 2026 Miami Beach Convention Center See you in Miami

      more
    • A New Milestone for SciVision - achieved certification under the European Union Medical Device Regulation (MDR).
    • A New Milestone for SciVision - achieved certification under the European Union Medical Device Regulation (MDR).

      A New Milestone for SciVision As the aesthetic medical industry enters the MDR era, only a limited number of manufacturers worldwide have successfully achieved certification under the European Union Medical Device Regulation (MDR). We are proud to announce that SciVision Biotech has officially obtained CE certification under the MDR framework for our Class III non-lidocaine dermal filler products. This achievement reflects our long-term commitment to product quality, patient safety, regulatory excellence, and international standards. The MDR certification marks another important milestone in SciVision’s global development and further strengthens our dedication to providing safe, innovative, and high-quality medical aesthetic solutions to healthcare professionals and patients worldwide.

      more

Cookies Policy

This website uses browser records (Cookies) to provide you with the best experience. The Cookies we use also include third-party Cookies.

For related information, please visit ourprivacy policy. If you choose to continue browsing or close this prompt, you agree to our terms of website use.